Twitter
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - Xeris Pharmaceuticals Q3 2022 Earnings Preview
November, 08 2022 01:04 PM
Xeris Pharmaceuticals Inc.
Xeris Pharmaceuticals ( NASDAQ: XERS ) is scheduled to announce Q3 earnings results on Wednesday, November 9th, before market open. The consensus EPS Estimate is -$0.15 (+61.5% Y/Y) and the consensus Revenue Estimate is $29.12M (+164.0% Y/Y). Over the last 2 years, XERS has beaten EPS estimates 50% of the time and has beaten revenue estimates 88% of the time. Over the last 3 months, EPS estimates have seen 3 upward revisions and 0 downward. Revenue estimates have seen 1 upward revision and 2 downward. For further details see:
Xeris Pharmaceuticals Q3 2022 Earnings Preview
Stock Information
Company Name:
Xeris Pharmaceuticals Inc.
Stock Symbol:
XERS
Market:
NASDAQ
Get XERS Alerts
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer .